OBN BioTuesday: A Spotlight on the latest research & innovation in the thriving FemTech market

The OBN team are pleased to announce details of our FemTech focused BioTuesday event, kindly hosted by FTI in London on Tuesday 6 February.

The evening has been designed to spotlight the latest research & innovation in the thriving FemTech market, which over the course of just a few years, has grown to encompass a range of technology-enabled, consumer-centric products and solutions.

FemTech companies are disrupting healthcare in a number of ways, including:

  • Improving care delivery via virtual clinics and direct to consumer services
  • Enabling self-care via the development of trackers and wearables, at-home diagnostics and solutions that are helping women take greater charge of their health and health-related data.
  • Improved diagnostics that are pushing the scientific frontier to address unmet medical needs
  • Addressing stigmatized areas such as menstrual health, sexual health, pelvic care and menopause 

Our keynote speakers will provide a broad update on the the latest innovation, funding, future growth expectations and most importantly, real-world patient impact of the treatments, diagnostics and solutions these exciting companies are producing. 


18.00 – 18.30 Guest arrivals and networking

18.30 – 19.00 Welcome & Keynote Presentations

19.00 - 20.00 Showcase Presentations featuring from a range of leading, innovative FemTech focused R&D companies

20.00 - 20.30 Audience & Presenter Q&A

20.30 – 21.30 Networking

About FTI Consulting

Over the last 40 years, FTI Consulting has grown to become a market-leading global consulting firm that brings together distinct capabilities and experts to serve as the trusted advisor to clients when they are facing their greatest opportunities and challenges. Each practice is a leader in its own right, staffed with experts recognized for the depth of their knowledge and a track record of making an impact. Collectively, FTI Consulting offers a comprehensive suite of services designed to assist clients across the business cycle—from proactive risk management to the ability to respond rapidly to unexpected crises and dynamic environments.


  • Angela Hobbs (Founder and CEO of Wilkinson Hall)

    Angela Hobbs

    Founder and CEO of Wilkinson Hall


    Angela Hobbs, a dedicated member of the OBN Board since 2021 and Chair of the People and Cultural Advisory Group, works as an Innovation Management consultant and Fractional COO. Driven by a commitment to narrow the gender health gap in workplaces, Angela actively endeavors to reshape contemporary work environments, placing a strong emphasis on fostering innovation across diverse businesses. In her role as the Resident Innovation Coach at Oxford University Innovation, she supports entrepreneurs in aligning feasibility, viability, and desirability in their value propositions and collaborating to address pressing challenges.
    She has an MSc in Sustainable Business from University of Bath and having successfully completed her Professional Executive Coaching qualification at Henley Business School in 2022, Angela is well-versed in her field. Beyond her active participation in various industry events as a speaker or panel member, she extends her expertise by coaching female founders and has founded a women in business program.
    As a lifelong learner, Angela derives joy from traveling, especially horse riding holidays, exploring art galleries, and long walks.

    view more
  • Stephanie Caird (Principal Associate at Mills & Reeve)

    Stephanie Caird

    Principal Associate at Mills & Reeve

  • Tess Cosad (Co-Founder & CEO of Béa Fertility)

    Tess Cosad

    Co-Founder & CEO of Béa Fertility

  • Jared Williams (Founder and CEO of Evelyn Health)

    Jared Williams

    Founder and CEO of Evelyn Health

  • Rob Milnes (CEO of viO HealthTech)

    Rob Milnes

    CEO of viO HealthTech


    Rob has over 30 years experience in financing and bringing ground-breaking medical technology and software to global markets, with the past 20 years focussed on women’s health. Co-inventor of 6 OvuSense patents and co-author of several clinical publications, he is also CEO of viO HealthTech Inc., the company’s wholly owned US subsidiary. Rob has worked for Roche, Oxford Instruments, and was formerly a member of the Operations Board of Huntleigh Healthcare following the successful sale and integration of the Sonicaid Fetal Monitoring and Medilog Cardiology businesses. He brings extensive experience in international sales & marketing, M&A, sub-contract manufacturing, finance and systems.

    view more
  • Karolina Afors (Medical Director of Medherant)

    Karolina Afors

    Medical Director of Medherant

    view more
  • Terri Cooper (Board Chair at Verso Biosense)

    Terri Cooper

    Board Chair at Verso Biosense

  • Peony Li (Founder and CEO of Jude)

    Peony Li

    Founder and CEO of Jude

    view more


FTI Consulting

200 Aldersgate
Aldersgate Street

United Kingdom

If you have any questions please contact Isabel Coleman

Contact Organizer

Show on map


OBN Member Ticket
Member Price Complimentary
OBN Member Additional Ticket
Member Price £25
Non-Member Ticket
Standard Price £50
Complimentary Student Ticket (Sold Out)

Complimentary registration available for Students

Standard Price Complimentary